NOVO-B.CO Novo Nordisk B A/S | DK0060534915
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 300.213.387.560 | 293.810.172.150 | 2.18% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 21,50 | 20,97 | 2.50% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 23 | 24 | 4.17% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |